These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [NONMEM approach for estimating population pharmacokinetic parameters of phenytoin in Chinese epileptics]. Rui JZ, Cai MH, Chu XM, Chen G. Yao Xue Xue Bao; 1995; 30(3):172-8. PubMed ID: 7639079 [Abstract] [Full Text] [Related]
28. Rapid and slow release phenytoin in epileptic patients at steady state: assessment of relative bioavailability utilizing Michaelis-Menten parameters. Sawchuk RJ, Pepin SM, Leppik IE, Gumnit RJ. J Pharmacokinet Biopharm; 1982 Aug; 10(4):383-91. PubMed ID: 7153871 [Abstract] [Full Text] [Related]
29. Classical Michaelis-Menten and system theory approach to modeling metabolite formation kinetics. Popović J. Eur J Drug Metab Pharmacokinet; 2004 Aug; 29(3):205-14. PubMed ID: 15537173 [Abstract] [Full Text] [Related]
31. Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data. Battino D, Croci D, Mamoli D, Messina S, Perucca E. Epilepsy Res; 2004 Oct; 59(2-3):155-65. PubMed ID: 15246117 [Abstract] [Full Text] [Related]
32. Utilization of Km for phenytoin dosage after folate addition to patient regimen. Berg MJ, Ebert BE, Rivey MP, Schottelius DD. Ther Drug Monit; 1987 Sep; 9(3):304-5. PubMed ID: 3672574 [Abstract] [Full Text] [Related]
33. Disposition of phenytoin in critically ill trauma patients. Boucher BA, Rodman JH, Fabian TC, Cupit GC, Ludden TM, West ME, Ray MW. Clin Pharm; 1987 Nov; 6(11):881-7. PubMed ID: 3677565 [Abstract] [Full Text] [Related]
37. Precautions in the use of Michaelis-Menten kinetics in the prediction of phenytoin levels. Jochsberger T. Drug Intell Clin Pharm; 1986 Nov; 20(7-8):605-6. PubMed ID: 3743419 [Abstract] [Full Text] [Related]